119 related articles for article (PubMed ID: 23013281)
1. Rat α-Fetoprotein binding affinities of a large set of structurally diverse chemicals elucidated the relationships between structures and binding affinities.
Hong H; Branham WS; Dial SL; Moland CL; Fang H; Shen J; Perkins R; Sheehan D; Tong W
Chem Res Toxicol; 2012 Nov; 25(11):2553-66. PubMed ID: 23013281
[TBL] [Abstract][Full Text] [Related]
2. Human sex hormone-binding globulin binding affinities of 125 structurally diverse chemicals and comparison with their binding to androgen receptor, estrogen receptor, and α-fetoprotein.
Hong H; Branham WS; Ng HW; Moland CL; Dial SL; Fang H; Perkins R; Sheehan D; Tong W
Toxicol Sci; 2015 Feb; 143(2):333-48. PubMed ID: 25349334
[TBL] [Abstract][Full Text] [Related]
3. Homology modeling, molecular docking, and molecular dynamics simulations elucidated α-fetoprotein binding modes.
Shen J; Zhang W; Fang H; Perkins R; Tong W; Hong H
BMC Bioinformatics; 2013; 14 Suppl 14(Suppl 14):S6. PubMed ID: 24266910
[TBL] [Abstract][Full Text] [Related]
4. Nature of the binding interaction for 50 structurally diverse chemicals with rat estrogen receptors.
Laws SC; Yavanhxay S; Cooper RL; Eldridge JC
Toxicol Sci; 2006 Nov; 94(1):46-56. PubMed ID: 16940337
[TBL] [Abstract][Full Text] [Related]
5. Study of 202 natural, synthetic, and environmental chemicals for binding to the androgen receptor.
Fang H; Tong W; Branham WS; Moland CL; Dial SL; Hong H; Xie Q; Perkins R; Owens W; Sheehan DM
Chem Res Toxicol; 2003 Oct; 16(10):1338-58. PubMed ID: 14565775
[TBL] [Abstract][Full Text] [Related]
6. QSAR prediction of estrogen activity for a large set of diverse chemicals under the guidance of OECD principles.
Liu H; Papa E; Gramatica P
Chem Res Toxicol; 2006 Nov; 19(11):1540-8. PubMed ID: 17112243
[TBL] [Abstract][Full Text] [Related]
7. Comparison of estrogen receptor alpha and beta subtypes based on comparative molecular field analysis (CoMFA).
Xing L; Welsh WJ; Tong W; Perkins R; Sheehan DM
SAR QSAR Environ Res; 1999; 10(2-3):215-37. PubMed ID: 10491851
[TBL] [Abstract][Full Text] [Related]
8. The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands.
Blair RM; Fang H; Branham WS; Hass BS; Dial SL; Moland CL; Tong W; Shi L; Perkins R; Sheehan DM
Toxicol Sci; 2000 Mar; 54(1):138-53. PubMed ID: 10746941
[TBL] [Abstract][Full Text] [Related]
9. An integrated "4-phase" approach for setting endocrine disruption screening priorities--phase I and II predictions of estrogen receptor binding affinity.
Shi L; Tong W; Fang H; Xie Q; Hong H; Perkins R; Wu J; Tu M; Blair RM; Branham WS; Waller C; Walker J; Sheehan DM
SAR QSAR Environ Res; 2002 Mar; 13(1):69-88. PubMed ID: 12074393
[TBL] [Abstract][Full Text] [Related]
10. Flavonoids inhibit estrogen binding to rat alpha-fetoprotein.
Baker ME; Medlock KL; Sheehan DM
Proc Soc Exp Biol Med; 1998 Mar; 217(3):317-21. PubMed ID: 9492341
[TBL] [Abstract][Full Text] [Related]
11. A surprising increase in the affinity of estrogen for rat alpha-fetoprotein after it is treated with N-ethylmaleimide.
Baker ME
Biochem Int; 1986 Feb; 12(2):331-40. PubMed ID: 2421727
[TBL] [Abstract][Full Text] [Related]
12. Molecular modeling for screening environmental chemicals for estrogenicity: use of the toxicant-target approach.
Rabinowitz JR; Little SB; Laws SC; Goldsmith MR
Chem Res Toxicol; 2009 Sep; 22(9):1594-602. PubMed ID: 19715353
[TBL] [Abstract][Full Text] [Related]
13. High affinity of nonesterified polyunsaturated fatty acids for rat alpha-fetoprotein (AFP).
Benassayag C; Vallette G; Delorme J; Savu L; Nunez EA
Oncodev Biol Med; 1980 Aug; 1(1):27-36. PubMed ID: 6169054
[TBL] [Abstract][Full Text] [Related]
14. [Estrogen binding activities of recombinant alpha-fetoproteins expressed in yeast].
Shahbazzadeh D
Hokkaido Igaku Zasshi; 1995 May; 70(3):473-83. PubMed ID: 7590598
[TBL] [Abstract][Full Text] [Related]
15. A Rat α-Fetoprotein Binding Activity Prediction Model to Facilitate Assessment of the Endocrine Disruption Potential of Environmental Chemicals.
Hong H; Shen J; Ng HW; Sakkiah S; Ye H; Ge W; Gong P; Xiao W; Tong W
Int J Environ Res Public Health; 2016 Mar; 13(4):372. PubMed ID: 27023588
[TBL] [Abstract][Full Text] [Related]
16. [Research advances on alpha-fetoprotein physiological function and clinical potential].
Yin ZF; Wang CH
Ai Zheng; 2003 Jan; 22(1):108-11. PubMed ID: 12561448
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the results of in vitro receptor binding assay to human estrogen receptor alpha and in vivo uterotrophic assay: comparative study with 65 selected chemicals.
Akahori Y; Nakai M; Yamasaki K; Takatsuki M; Shimohigashi Y; Ohtaki M
Toxicol In Vitro; 2008 Feb; 22(1):225-31. PubMed ID: 17904329
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of an average mammalian estrogen receptor-based QSAR model.
Mekenya O; Kamenska V; Serafimova R; Poellinger L; Brouwer A; Walker J
SAR QSAR Environ Res; 2002 Oct; 13(6):579-95. PubMed ID: 12479373
[TBL] [Abstract][Full Text] [Related]
19. Expression of an oncodevelopmental gene product (alpha-fetoprotein) during fetal development and adult oncogenesis.
Sell S; Becker FF; Leffert HL; Watabe L
Cancer Res; 1976 Nov; 36(11 Pt. 2):4239-49. PubMed ID: 61804
[TBL] [Abstract][Full Text] [Related]
20. Binding specificity of rat alpha-fetoprotein for a series of estrogen derivatives: studies using equilibrium and nonequilibrium binding techniques.
Payne DW; Katzenellenbogen JA
Endocrinology; 1979 Sep; 105(3):745-53. PubMed ID: 89027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
